Short answer
IBEX Ltd (IBEX) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $175M (up 15.9% year over year) with net income of $15M.
Q3 2026 key financials · XBRL
- Revenue
- $175M
- +15.9% YoY
- Net income
- $15M
- +22.7% YoY
- Operating margin
- 10.4%
- EPS (diluted)
- $0.99
- +20.7% YoY
Source: XBRL data from the IBEX Ltd (IBEX) Q3 2026 10-Q on SEC EDGAR. USD.
IBEX Ltd Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $175.2M, up 15.9% YoY from $151.2M, led by HealthTech growth of $8.7M, or 39.9%
- Operating margin 10.4% vs 9.1% YoY, net income margin 8.4% vs 8.0%, adjusted EBITDA margin 14.4% vs 12.9%
- Worst-performing vertical: FinTech revenue down $0.3M, or 1.7% YoY
- Operating cash flow $16.3M vs $15.7M, capital expenditures $7.2M, free cash flow $9.2M vs $8.0M
- Emerging headwinds: wage pressure, inflation, labor shortages, client shifts toward lower-priced offshore delivery, evolving AI regulation and adoption
Risk Factors
- No material changes to Annual Report risk factors
- Carried-forward financial risk: adverse effects on financial position, results, or cash flows
- Unknown or currently immaterial risks could materially harm operations
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other IBEX Ltd quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.